161 related articles for article (PubMed ID: 36437828)
21. [Electroacupuncture improves behavioral activities by suppressing neuroinflammation and TLR4/NF-κB signaling in substantia nigra of midbrain in Parkinson's disease rats].
Qi L; Wang Y; Li YN; Guo L; Ma J
Zhen Ci Yan Jiu; 2021 Nov; 46(11):929-34. PubMed ID: 34865329
[TBL] [Abstract][Full Text] [Related]
22. Glutathione
Jewett M; Dickson E; Brolin K; Negrini M; Jimenez-Ferrer I; Swanberg M
Front Neurol; 2018; 9():222. PubMed ID: 29681884
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone.
Javed H; Azimullah S; Abul Khair SB; Ojha S; Haque ME
BMC Neurosci; 2016 Aug; 17(1):58. PubMed ID: 27549180
[TBL] [Abstract][Full Text] [Related]
24. Levodopa Therapy for Parkinson's Disease: History, Current Status and Perspectives.
Bogetofte H; Alamyar A; Blaabjerg M; Meyer M
CNS Neurol Disord Drug Targets; 2020; 19(8):572-583. PubMed ID: 32703142
[TBL] [Abstract][Full Text] [Related]
25. [Electroacupuncture improved locomotor function by regulating expression of tyrosine hydroxylase and α-synuclein proteins and transcription activating factor 6 and transcription factor X box binding protein 1 mRNAs in substantia nigra of rats with Parkinson's disease].
Ma J; Yuan L; Wang SJ; Lei J; Wang Y; Li YN; Yu BL
Zhen Ci Yan Jiu; 2019 Nov; 44(11):805-9. PubMed ID: 31777229
[TBL] [Abstract][Full Text] [Related]
26. The potential neuroprotective effect of diosmin in rotenone-induced model of Parkinson's disease in rats.
Habib CN; Mohamed MR; Tadros MG; Tolba MF; Menze ET; Masoud SI
Eur J Pharmacol; 2022 Jan; 914():174573. PubMed ID: 34656609
[TBL] [Abstract][Full Text] [Related]
27. Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERβ/Nrf2/HO-1 signaling.
Baluchnejadmojarad T; Rabiee N; Zabihnejad S; Roghani M
Brain Res; 2017 May; 1662():23-30. PubMed ID: 28238669
[TBL] [Abstract][Full Text] [Related]
28. Benefits of betanin in rotenone-induced Parkinson mice.
Thong-Asa W; Jedsadavitayakol S; Jutarattananon S
Metab Brain Dis; 2021 Dec; 36(8):2567-2577. PubMed ID: 34436745
[TBL] [Abstract][Full Text] [Related]
29. The neuroprotective effects of hydro-alcoholic extract of olive (Olea europaea L.) leaf on rotenone-induced Parkinson's disease in rat.
Sarbishegi M; Charkhat Gorgich EA; Khajavi O; Komeili G; Salimi S
Metab Brain Dis; 2018 Feb; 33(1):79-88. PubMed ID: 29039078
[TBL] [Abstract][Full Text] [Related]
30. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
31. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.
Farrand AQ; Helke KL; Gregory RA; Gooz M; Hinson VK; Boger HA
Brain Stimul; 2017; 10(6):1045-1054. PubMed ID: 28918943
[TBL] [Abstract][Full Text] [Related]
32. Effect of
Tang L; Chen C; Xia B; Wu W; Wei R; Zhu G; Tang J; Zhou X; Liang Y; Zhang ZN; Lu Y; Yang Y; Zhao Y
Evid Based Complement Alternat Med; 2020; 2020():9838295. PubMed ID: 32655672
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory potential of plant secondary metabolites on anti-Parkinsonian drug targets: Relevance to pathophysiology, and motor and non-motor behavioural abnormalities.
Mazumder MK; Borah A; Choudhury S
Med Hypotheses; 2020 Apr; 137():109544. PubMed ID: 31954292
[TBL] [Abstract][Full Text] [Related]
34. MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease.
Sampaio TF; Dos Santos EUD; de Lima GDC; Dos Anjos RSG; da Silva RC; Asano AGC; Asano NMJ; Crovella S; de Souza PRE
J Clin Pharmacol; 2018 Jul; 58(7):920-926. PubMed ID: 29578580
[TBL] [Abstract][Full Text] [Related]
35. Adulthood Exposure to Lipopolysaccharide Exacerbates the Neurotoxic and Inflammatory Effects of Rotenone in the Substantia Nigra.
Huang C; Zhu L; Li H; Shi FG; Wang GQ; Wei YZ; Liu J; Zhang F
Front Mol Neurosci; 2017; 10():131. PubMed ID: 28533741
[TBL] [Abstract][Full Text] [Related]
36. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
[TBL] [Abstract][Full Text] [Related]
37. The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta.
Cankara FN; Günaydın C; Bilge SS; Özmen Ö; Kortholt A
Neurosci Lett; 2020 Nov; 738():135308. PubMed ID: 32932183
[TBL] [Abstract][Full Text] [Related]
38. Entacapone, a catechol-O-methyltransferase inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson's disease induced by Japanese encephalitis virus.
Hamaue N; Ogata A; Terado M; Tsuchida S; Yabe I; Sasaki H; Hirafuji M; Togashi H; Aoki T
Brain Res; 2010 Jan; 1309():110-5. PubMed ID: 19879254
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotective effect of agmatine (decarboxylated l-arginine) against oxidative stress and neuroinflammation in rotenone model of Parkinson's disease.
El-Sayed EK; Ahmed A; Morsy EE; Nofal S
Hum Exp Toxicol; 2019 Feb; 38(2):173-184. PubMed ID: 30001633
[TBL] [Abstract][Full Text] [Related]
40. [Effect of electroacupuncture regulating NLRP3/Caspase-1 pathway on pyroptosis of dopaminergic neurons in rats with Parkinson's disease].
Liu YY; Guo YB; Zhai HY; Lei DB; Wang H; Zhao SC; Liu PJ
Zhen Ci Yan Jiu; 2022 Nov; 47(11):983-92. PubMed ID: 36453675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
